Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management

Bibliographic Details
Title:	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
Authors:	Ladan Panahi, George Udeani, Steven Ho, Brett Knox, Jason Maille
Source:	Medicina, Vol 57, Iss 11, p 1173 (2021)
Publisher Information:	MDPI AG, 2021.
Publication Year:	2021
Collection:	LCC:Medicine (General)
Subject Terms:	obstructive sleep apnea (OSA), pharmacotherapy, Medicine (General), R5-920
More Details:	Nearly a billion adults around the world are affected by a disease that is characterized by upper airway collapse while sleeping called obstructive sleep apnea or OSA. The progression and lasting effects of untreated OSA include an increased risk of diabetes mellitus, hypertension, stroke, and heart failure. There is often a decrease in quality-of-life scores and an increased rate of mortality in these patients. The most common and effective treatments for OSA include continuous positive airway pressure (CPAP), surgical treatment, behavior modification, changes in lifestyle, and mandibular advancement devices. There are currently no pharmacological options approved for the standard treatment of OSA. There are, however, some pharmacological treatments for daytime sleepiness caused by OSA. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications.
Document Type:	article
File Description:	electronic resource
Language:	English
ISSN:	1648-9144 1010-660X
Relation:	https://www.mdpi.com/1648-9144/57/11/1173; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144
DOI:	10.3390/medicina57111173
Access URL:	https://doaj.org/article/02393d22565a4149b9316269f0724fc8
Accession Number:	edsdoj.02393d22565a4149b9316269f0724fc8
Database:	Directory of Open Access Journals

More Details
ISSN:	16489144 1010660X
DOI:	10.3390/medicina57111173
Published in:	Medicina
Language:	English